136 related articles for article (PubMed ID: 18001172)
1. An evaluation of a novel chick cardiomyocyte micromass culture assay with two teratogens/embryotoxins associated with heart defects.
Hurst HS; Clothier RH; Pratten M
Altern Lab Anim; 2007 Oct; 35(5):505-14. PubMed ID: 18001172
[TBL] [Abstract][Full Text] [Related]
2. Effects of multivitamins and known teratogens on chick cardiomyocytes micromass culture assay.
Memon S; Pratten M
Iran J Basic Med Sci; 2013 Sep; 16(9):996-1003. PubMed ID: 24171079
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the chick cardiomyocyte micromass system for identification of teratogens in a blind trial.
Hurst H; Clothier RH; Pratten M
Reprod Toxicol; 2009 Dec; 28(4):503-10. PubMed ID: 19646523
[TBL] [Abstract][Full Text] [Related]
4. Developmental cardiotoxicity effects of four commonly used antiepileptic drugs in embryonic chick heart micromass culture and embryonic stem cell culture systems.
Ahir BK; Pratten MK
Toxicol In Vitro; 2014 Aug; 28(5):948-60. PubMed ID: 24768975
[TBL] [Abstract][Full Text] [Related]
5. The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid.
Riebeling C; Pirow R; Becker K; Buesen R; Eikel D; Kaltenhäuser J; Meyer F; Nau H; Slawik B; Visan A; Volland J; Spielmann H; Luch A; Seiler A
Toxicol Sci; 2011 Apr; 120(2):360-70. PubMed ID: 21227905
[TBL] [Abstract][Full Text] [Related]
6. Association of anxiolytic drugs diazepam and lorazepam, and the antiepileptic valproate, with heart defects--effects on cardiomyocytes in micromass (MM) and embryonic stem cell culture.
Ahir BK; Pratten MK
Reprod Toxicol; 2011 Jan; 31(1):66-74. PubMed ID: 20888408
[TBL] [Abstract][Full Text] [Related]
7. A novel human pluripotent stem cell-based assay to predict developmental toxicity.
Lauschke K; Rosenmai AK; Meiser I; Neubauer JC; Schmidt K; Rasmussen MA; Holst B; Taxvig C; Emnéus JK; Vinggaard AM
Arch Toxicol; 2020 Nov; 94(11):3831-3846. PubMed ID: 32700165
[TBL] [Abstract][Full Text] [Related]
8. Chick Embryonic Cardiomyocyte Micromass System for Assessing Developmental Cardiotoxicity of Drugs.
Qureshi WMS; Pratten MK
Methods Mol Biol; 2018; 1797():147-163. PubMed ID: 29896690
[TBL] [Abstract][Full Text] [Related]
9. The impact of caffeine on connexin expression in the embryonic chick cardiomyocyte micromass culture system.
Ahir BK; Pratten MK
J Appl Toxicol; 2016 Jul; 36(7):903-13. PubMed ID: 26304238
[TBL] [Abstract][Full Text] [Related]
10. Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies.
Konala VBR; Nandakumar S; Surendran H; Datar S; Bhonde R; Pal R
Toxicol Appl Pharmacol; 2021 Dec; 433():115792. PubMed ID: 34742744
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen species.
Na L; Wartenberg M; Nau H; Hescheler J; Sauer H
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):174-80. PubMed ID: 12797459
[TBL] [Abstract][Full Text] [Related]
12. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
[TBL] [Abstract][Full Text] [Related]
13. The Phosphorylation State of GSK3β Serine 9 Correlated to the Development of Valproic Acid-Associated Fetal Cardiac Teratogenicity, Fetal VPA Syndrome, Rescued by Folic Acid Administration.
Yu WH; Ho YL; Huang PT; Chu SL; Tsai HJ; Liou HH
Cardiovasc Toxicol; 2016 Jan; 16(1):34-45. PubMed ID: 25724324
[TBL] [Abstract][Full Text] [Related]
14. Modified Xenopus laevis approach (R-FETAX) as an alternative test for the evaluation of foetal valproate spectrum disorder.
Battistoni M; Bacchetta R; Di Renzo F; Metruccio F; Moretto A; Menegola E
Reprod Toxicol; 2022 Jan; 107():140-149. PubMed ID: 34923091
[TBL] [Abstract][Full Text] [Related]
15. Primary cell and micromass culture in assessing developmental toxicity.
Pratten M; Ahir BK; Smith-Hurst H; Memon S; Mutch P; Cumberland P
Methods Mol Biol; 2012; 889():115-46. PubMed ID: 22669663
[TBL] [Abstract][Full Text] [Related]
16. Micromass Methods for the Evaluation of Developmental Toxicants.
Mohammed OJ; Pratten MK
Methods Mol Biol; 2019; 1965():49-72. PubMed ID: 31069668
[TBL] [Abstract][Full Text] [Related]
17. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.
Brown NA
Altern Lab Anim; 2002; 30(2):177-98. PubMed ID: 11971754
[TBL] [Abstract][Full Text] [Related]
18. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
19. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
Suzuki N; Ando S; Yamashita N; Horie N; Saito K
Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
